In re Loestrin 24 FE Antitrust Litigation, 433 F.Supp.3d 274 (2019)

This opinion cited by 25 cases:

• OHIO v. AMERICAN EXPRESS CO., 138 S.Ct. 2274 (2018)
  Supreme Court of the United States   |  Jun. 25, 2018  | Cited 28 times
• IN RE ASACOL ANTITRUST LITIGATION, 907 F.3d 42 (2018)
  Court of Appeals for the First Circuit   |  Oct. 15, 2018  | Cited 24 times
• UNITED FOOD & COMM. WORK. v. NOVARTIS PHARMACEUT., 902 F.3d 1 (2018)
  Court of Appeals for the First Circuit   |  Aug. 21, 2018  | Cited 1 times
• IN RE WELLBUTRIN XL ANTITRUST LITIGATION, 868 F.3d 132 (2017)
  Court of Appeals for the Third Circuit   |  Aug. 09, 2017  | Cited 26 times
• In re Opana ER Antritrust Litigation, 162 F.Supp.3d 704 (2016)
  District Court, N.D. Illinois   |  Feb. 10, 2016  | Cited 20 times
• IN RE NEXIUM (ESOMEPRAZOLE) ANTITRUST LITIGATION, 842 F.3d 34 (2016)
  Court of Appeals for the First Circuit   |  Nov. 21, 2016  | Cited 21 times
• KAUFMAN v. CVS CAREMARK CORPORATION, 836 F.3d 88 (2016)
  Court of Appeals for the First Circuit   |  Sep. 06, 2016  | Cited 8 times
• IN RE LOESTRIN 24 FE ANTITRUST LITIGATION, 814 F.3d 538 (2016)
  Court of Appeals for the First Circuit   |  Feb. 22, 2016  | Cited 21 times
• IN RE WELLBUTRIN XL ANTITRUST LITIGATION, 133 F.Supp.3d 734 (2015)
  District Court, E.D. Pennsylvania   |  Sep. 23, 2015  | Cited 11 times
• EXERGEN CORPORATION v. KAZ USA, INC., 120 F.Supp.3d 1 (2015)
  District Court, D. Massachusetts   |  Aug. 10, 2015  | Cited 3 times
• IN RE AGGRENOX ANTITRUST LITIGATION, 94 F.Supp.3d 224 (2015)
  District Court, D. Connecticut   |  Mar. 23, 2015  | Cited 33 times
• KING DRUG CO. OF FLORENCE, INC. v. CEPHALON, INC., 88 F.Supp.3d 402 (2015)
  District Court, E.D. Pennsylvania   |  Jan. 28, 2015  | Cited 5 times
• NEW YORK EX REL. SCHNEIDERMAN v. ACTAVIS PLC, 787 F.3d 638 (2015)
  Court of Appeals for the Second Circuit   |  May 22, 2015  | Cited 90 times
• In re Niaspan Antitrust Litigation, 42 F.Supp.3d 735 (2014)
  District Court, E.D. Pennsylvania   |  Sep. 08, 2014  | Cited 32 times
• In re Nexium (Esomeprazole) Antitrust Litigation, 42 F.Supp.3d 231 (2014)
  District Court, D. Massachusetts   |  Sep. 04, 2014  | Cited 14 times
• ALEX AND ANI, LLC v. ELITE LEVEL CONSULTING, LLC, 31 F.Supp.3d 365 (2014)
  District Court, D. Rhode Island   |  Jul. 18, 2014  | Cited 5 times
• TYCO HEALTHCARE GROUP LP v. MUTUAL PHARMACEUTICAL, 762 F.3d 1338 (2014)
  Court of Appeals for the Federal Circuit   |  Aug. 06, 2014  | Cited 17 times
• F.T.C. v. ACTAVIS, INC., 133 S.Ct. 2223 (2013)
  Supreme Court of the United States   |  Jun. 17, 2013  | Cited 144 times
• IN RE NEXIUM (ESOMEPRAZOLE) ANTITRUST LITIGATION, 968 F.Supp.2d 367 (2013)
  District Court, D. Massachusetts   |  Sep. 11, 2013  | Cited 42 times
• IN RE ANDROGEL ANTITRUST LITIGATION (NO. II), 888 F.Supp.2d 1336 (2012)
  District Court, N.D. Georgia   |  Oct. 30, 2012  | Cited 6 times
• RITZ CAMERA & IMAGE, LLC v. SANDISK CORP., 700 F.3d 503 (2012)
  Court of Appeals for the Federal Circuit   |  Nov. 20, 2012  | Cited 19 times
• MICROSOFT CORP. v. I4I LTD. PARTNERSHIP, 131 S.Ct. 2238 (2011)
  Supreme Court of the United States   |  Jun. 09, 2011  | Cited 635 times
• THERASENSE, INC. v. BECTON, DICKINSON AND CO., 649 F.3d 1276 (2011)
  Court of Appeals for the Federal Circuit   |  May 25, 2011  | Cited 397 times
• BARTLETT v. MUTUAL PHARMACEUTICAL CO., INC., 742 F.Supp.2d 182 (2010)
  District Court, D. New Hampshire   |  Jul. 22, 2010  | Cited 14 times
• AIBT. v. VARIAN SEMICONDUCTOR EQUIPMENT ASSOCIATES, 721 F.Supp.2d 62 (2010)
  District Court, D. Massachusetts   |  Jul. 02, 2010  | Cited 23 times